Pharmx Technologies Ltd Suspended from ASX Quotation
Key points
- Pharmx Technologies Ltd (PHX) suspended from ASX quotation
- Trading halted pending release of non-market sensitive announcement
- Suspension to remain until announcement released and reinstatement appropriate
Full summary
Pharmx Technologies Ltd (PHX) has been immediately suspended from quotation on the Australian Securities Exchange (ASX) under Listing Rule 17.3.2 to prevent a disorderly or uninformed market. Trading in PHX's securities was halted at 11:01 AM AEST Friday, 11 July 2025 under ASX Listing Rule 17.1, pending the release of a market sensitive announcement. However, PHX has provided an announcement to ASX that ASX does not consider to be market sensitive. PHX's securities will remain suspended until the non-sensitive announcement is released to the market, and it is otherwise appropriate for PHX's securities to be reinstated to quotation.
Summary generated by a large language model. Please interpret with care.